Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.

Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.

Cytotoxic T lymphocytes recognize short peptides presented in association with MHC class I (MHCI) molecules on the surface of target cells. The Ag specificity of T lymphocytes is conferred by the TCR, but invariable regions of the peptide-MHCI (pMHCI) molecule also interact with the cell surface gly...

Full description

Bibliographic Details
Main Authors: Wooldridge, L, Hutchinson, S, Choi, E, Lissina, A, Jones, E, Mirza, F, Dunbar, P, Price, D, Cerundolo, V, Sewell, A
Format: Journal article
Language:English
Published: 2003

Similar Items

Similar Items